Nilotinib for the frontline treatment of chronic myeloid leukemia carrying the p230 transcript: Dream or reality?

Maurizio Capuozzo, Alessandro Ottaiano, Eduardo Nava, Stefania Cascone, Claudia Cinque, Adriano Vercellone, Corinne Scognamiglio, Emilia Palumbo, Rosario V. Iaffaioli

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number00017
JournalFrontiers in Oncology
Volume4 FEB
DOIs
Publication statusPublished - 2014

Keywords

  • Chromosomal translocation
  • Chronic myeloid leukemia
  • E19a2 rearrangement
  • Nilotinib
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this